RT Journal Article
SR Electronic
T1 Cholera deaths during outbreaks in Uvira, eastern Democratic Republic of the Congo, 10-35 months after mass vaccination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.26.23290528
DO 10.1101/2023.05.26.23290528
A1 Bugeme, Patrick Musole
A1 Xu, Hanmeng
A1 Hutchins, Chloe
A1 Hulse, Juan Dent
A1 Saidi, Jaime Mufitini
A1 Rumedeka, Baron Bashige
A1 Itongwa, Moïse
A1 Mashauri, Joël Faraja Zigashane
A1 Lulela, Faraja Masembe
A1 Bengehya, Justin
A1 Kulondwa, Jean-Claude
A1 Debes, Amanda K
A1 Ciglenecki, Iza
A1 Tshiwedi, Esperance
A1 Kitoga, Faida
A1 Bodisa-Matamu, Tavia
A1 Nadège, Taty
A1 Kavunga-Membo, Hugo
A1 Lunguya, Octavie
A1 Welo, Placide Okitayemba
A1 Knee, Jackie
A1 Mukadi-Bamuleka, Daniel
A1 Azman, Andrew S.
A1 Malembaka, Espoir Bwenge
YR 2023
UL http://medrxiv.org/content/early/2023/10/23/2023.05.26.23290528.abstract
AB Our understanding of the burden and drivers of cholera mortality is hampered by limited surveillance and confirmation capacity. Leveraging enhanced clinical and laboratory surveillance in the cholera-endemic community of Uvira, eastern Democratic Republic of Congo, we describe cholera deaths across three epidemics between September 2021-September 2023, following mass vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Wellcome Trust and Gavi (GAVI-RFP-2019-062).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approvals were obtained from Institutional Review Boards of the Johns Hopkins Bloomberg School of Public Health (IRB00015785), The London School of Hygiene and Tropical Medicine (25365) and the Ecole de Sante Publique at the University of Kinshasa (ESP/CE/65/2021). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.